Tryp Therapeutics Announces Collaboration with Researchers at the University of Wisconsin-Madison

MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary...

Psygen Announces use of Psilocybin in Human Trial and Provides Update...

Mydecine Completes Spin-Out of U.S. Cannabis Assets

PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment...

Lobe Announces Krysalis VX Innovations Inc., a Company Equally Owned by...

Psychedelics and Perception Part 2: The First Era of Research

Anima Mundi: Psychedelics and The Ensouled Earth

Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded...

MindMed Announces Strategic Research Collaboration with Sphere Health

Load more